Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type
The Journal of Pathology · 2023
DOI: 10.1002/path.6205 ↗At a glance
Journal article in The Journal of Pathology, 2023. Written by Thijmen Sijnesael and 8 co-authors. Institution: Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. Major MEDLINE topics: Breast Neoplasms, Carcinoma, Lobular, Carcinoma, Ductal, Breast. Cited 7 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: Breast Cancer Now, European Cooperation in Science and Technology, KWF Kankerbestrijding.
Abstract (original language)
Invasive lobular carcinoma (ILC) is a low‐ to intermediate‐grade histological breast cancer type caused by mutational inactivation of E‐cadherin function, resulting in the acquisition of anchorage independence (anoikis resistance). Most ILC cases express estrogen receptors, but options are limited in relapsed endocrine‐refractory disease as ILC tends to be less responsive to standard chemotherapy. Moreover, ILC can relapse after >15 years, an event that currently cannot be predicted. E‐cadherin inactivation leads to p120‐catenin‐dependent relief of the transcriptional repressor Kaiso (ZBTB33) and activation of canonical Kaiso target genes. Here, we examined whether an anchorage‐independent and ILC‐specific transcriptional program correlated with clinical parameters in breast cancer. Based on the presence of a canonical Kaiso‐binding consensus sequence (cKBS) in the promoters of genes that are upregulated under anchorage‐independent conditions, we defined an ILC‐specific anoikis resistance transcriptome (ART). Converting the ART genes into human orthologs and adding published Kaiso target genes resulted in the Kaiso‐specific ART (KART) 33‐gene signature, used subsequently to study correlations with histological and clinical variables in primary breast cancer. Using publicly available data for ER POS Her2 NEG breast cancer, we found that expression of KART was positively associated with the histological ILC breast cancer type ( p < 2.7E‐07). KART expression associated with younger patients in all invasive breast cancers and smaller tumors in invasive ductal carcinoma of no special type (IDC‐NST) (
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Laboratory for Translational Breast Cancer Research, Katholieke Universiteit Leuven, Leuven, Belgium.
- Department of Biology, McMaster University, Hamilton, ON, Canada.
ORCID profiles: Thijmen Sijnesael, François Richard, Max Ak Rätze, Thijs Koorman, Christine Desmedt, Patrick Wb Derksen
Funding
- Breast Cancer Now
- European Cooperation in Science and Technology
- KWF Kankerbestrijding
- ZonMw
Cite
APA
Sijnesael, T., Richard, F., Rätze, M. A., Koorman, T., Bassey-Archibong, B., Rohof, C., Daniel, J., Desmedt, C., & Derksen, P. W. (2023). Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type. The Journal of Pathology. https://doi.org/10.1002/path.6205
Vancouver
Sijnesael T, Richard F, Rätze MA, Koorman T, Bassey-Archibong B, Rohof C, et al. Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type. The Journal of Pathology. 2023. doi:10.1002/path.6205
BibTeX
@article{Sijnesael2023,
author = {Sijnesael, Thijmen and Richard, François and Rätze, Max Ak and Koorman, Thijs and Bassey-Archibong, Blessing and Rohof, Christa and Daniel, Juliet and Desmedt, Christine and Derksen, Patrick Wb},
title = {Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type},
journal = {The Journal of Pathology},
year = {2023},
doi = {10.1002/path.6205}
}
EUVIMED